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Previewsauthors are appropriately restrained in
pushing the phytoalexin angle, and they
note the intriguing alternative that daidzein
or related compounds may regulate host
defense or pathogen virulence (for exam-
ples, see Bednarek and Osbourn, 2009;
and Mandal et al., 2010). In addition,
HopZ1 effectors may have multiple
targets, and it is possible that the main
raison d’etre of HopZ1b is suppression of
other host targets. It seems unlikely that
the biochemical activity of marking
GmHID1 for degradation has been sus-
tained without evolutionary selective
advantage, especially in light of the data
showing improved bacterial growth on
plants with reduced GmHID1 expression.
But even if GmHID1 degradation is
HopZ1b’s primary function, it remains to
be directly shown whether or not phyto-
alexin suppression is the main benefit
conferred by HopZ1b.170 Cell Host & Microbe 9, March 17, 2011 ªHence, in future work, along with deter-
mining whether HopZ1b is an acetyltrans-
ferase as opposed to a cysteine protease,
three broader questions will be important
to address. Does HopZ1b reduce the
abundance of the phytoalexins that
constrain bacterial growth in the natural
infection court?What are the other targets
of HopZ1b? Do soybean isoflavones play
other roles in defense induction or modu-
lation of bacterial virulence, separate from
any direct antimicrobial activity? Regard-
less of the answers, Ma’s group has
established a new category in the known
repertoire of bacterial effectors, and pro-
vided incentive for renewed attention to
an old friend: plant phytoalexins.REFERENCES
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The early establishment of a reservoir of latently infected T cells is a sobering obstacle to HIV eradication, in
spite of the efficacy of current antiretroviral therapies. That latent proviruses might also hide in multipotent
hematopoietic stem cells suggests an even more formidable challenge and potentially has therapeutic
implications.Quiescent T cells have long been known to
represent thequantitativelymost important
latent HIV reservoir (Finzi et al., 1997).
Because a fully resting T lymphocyte is
not permissive to the early steps of viral
replication, current models postulate that
after HIV infects T cells activated by
antigen- or cytokine-mediated stimulation,
some of these subsequently return to
quiescence, notably as long-term memory
T lymphocytes, where the provirus
becomes silent. The T cell-based HIV
reservoir is established from the earliest
times of infection and is maintained in
partbyhomeostaticproliferation (Chomontet al., 2009). Although its size may be
reduced when highly active antiretroviral
therapy (HAART) is initiated very early,
mathematical models predict that viral
eradication could take up to several
decadesunder conditionsofcompleteviral
suppression (Rong and Perelson, 2009).
Last year, Kathleen Collins and
colleagues reported that HIV-1 can infect
andkillmultipotenthematopoieticprogen-
itor cells (Carter et al., 2010). They also
noted that in a fraction of these cells,
infection was not lethal, but led to latent
proviruses, the expression of which was
reactivated by myeloid differentiation.Furthermore, suggesting the clinical rele-
vance of this observation, they demon-
strated that cells positive for CD34, a
marker of hematopoietic progenitor cells,
whichwere purified from the bonemarrow
of HIV-infected individuals could be
induced by cytokines to produce virus,
even when isolated from patients whose
viremia had been efficiently HAART-sup-
pressed for extensive times.
Following up on these results, Carter
et al. now report an important caveat
(Carter et al., 2011). Indeed, they found
that not all HIV strains can infect early
blood progenitors, only those bearing
Figure 1. A Two-Step Reservoir?
Initial transmission and early spread of HIV infection are mediated primarily by R5-tropic viruses. Infection
of CD4+ T lymphocytes results in the establishment of a reservoir of latently infected resting cells that can
bemaintained by homeostatic proliferation and cell activation. At later stages, X4-tropic HIV isolates even-
tually emerge, and this switch of dominance from R5-tropic to X4-tropic HIV correlates with rapid disease
progression. CXCR4-tropic viruses can infect multipotent HSCs, which might represent a truly permanent
source of virus in infected individuals.
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Previewsa so-called X4 envelope. Viral entry, the
very first step of HIV infection, is mediated
by interactions of the virion surface glyco-
protein Env with CD4 and one of two
chemokine receptors, either CCR5 or
CXCR4.Which of these is utilized is deter-
mined by what amino acids are present at
specific positions within Env, the nature of
which thereby defines CCR5- (or R5-)
tropic versus CXCR4- (or X4-) tropic
isolates. During the natural course of
HIV infection, usually R5-tropic viruses
mediate the initial transmission and early
spread, while the appearance of their
X4-tropic counterparts often coincides
with disease acceleration and has poor
prognostic value, although whether this
is cause or effect is still debated (Mosier,
2009). Interestingly,CXCR4 is the receptor
for SDF1 (stromal cell-derived factor 1),
and the signaling event resulting from their
interaction is essential for the homing of
hematopoietic stem cells (HSCs) to the
bone marrow (Peled et al., 1999).Carter et al. take their finding as a basis
to suggest that the poor evolution associ-
ated with the emergence of X4-tropic
isolates may be due to the seeding and
destruction of multipotent hematopoietic
progenitors and to the resulting
decreased ability to replenish peripheral
stocks of CD4+ T cells. In support of their
proposal, they note an inverse correlation
between bone marrow mononuclear
cellularity and years postdiagnosis in
high-viral-load (plasma viremia >50,000
RNA genome copies/ml) individuals, but
not in those fully controlled (undetectable
viremia) by HAART. However, even in
highly viremic individuals, the percentage
of infected HSCs appears to be too low
(from 2 to 40 HIV genomes per 10,000
CD34+ cells, according to Carter et al.’s
previous study [Carter et al., 2010]) to
have a global impact on bone marrow
functions. Accordingly, it seems more
likely that other factors, such as the
chronic inflammatory status that accom-Cell Host & Microbepanies long-term uncontrolled viral repli-
cation, play a more important role in this
process (Brenchley et al., 2006).
Irrespectively, an important question re-
mained: were HIV-infected CD34+ cells
just early hematopoietic progenitors with
a reassuringly finite life span or true stem
cells capable of multipotent self-renewal?
Raising the spectrum of an indefectible
HIV reservoir, Collins and colleagues
provide evidence for the latter (Carter
et al., 2011). When monitoring the fate
of genetically marked cells in humans is
not an option, the mouse xenograft
system is a good surrogate model to
assess the true nature of putative HSCs.
Carter et al. thus took advantage of a repli-
cation-defective, GFP-expressing, HIV-
1-derived lentiviral vector coated with an
X4-tropic HIV-1 envelope to ask whether
it could stably integrate into the genome
of human bone-marrow-derived CD34+
cells capable of reconstituting all blood
lineages in sublethally irradiated immuno-
deficient NOD/SCID IL-2Rgnull mice.
Amongsevenmice successfully engrafted
with cells exposed to such viral particles,
five carried in their peripheral blood GFP+
cells of both the lymphoid and myeloid
lineages for at least 20 weeks after
transplantation. Furthermore, in all these
animals the frequency of circulating
GFP+ cells increased after 8–10 weeks
posttransplant. Since only true HSCs can
maintain multilineage reconstitution for
more than 4–6 weeks in this model, these
data demonstrate that cells with multipo-
tent self-renewal capacity had been
successfully transducedby their exposure
to X4-tropic HIV-derived virions before
transplantation.
HIV-1 is thus capable of infecting
a cellular target, the HSC, which in hu-
mans is known to have life-long self-re-
newing potential. However, viral gene
expression, a prerequisite for cell killing
by either virus-induced cytopathic effects
or virus-specific cytotoxic T cells, is not
induced until HSCs differentiate into
more mature progenitors. Because HSCs
undergo asymmetric division, where one
daughter cell becomes a committed
progenitor while the other remains amulti-
potent stem cell, it implies that the HSC-
based HIV reservoir might well be perma-
nent, nomatter howsmall in size (Figure 1).
Recent efforts aimed at curing HIV-
infected individuals have focused on
the possibility that latent reservoirs9, March 17, 2011 ª2011 Elsevier Inc. 171
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Previewscould be purged by pharmacological
manipulations, combining HAART with
agents aimed at forcing viral expression
(reviewed in Trono et al., 2010). With
primarily a T lymphocyte-based latent
reservoir in mind, various combinations
of T cell activators, inhibitors of histone-
modifying enzymes, and blockers of
DNA methylation have been tested.
However, there is little evidence so far
that latently infected, resting CD4+
T cells were destroyed upon exposure to
purging agents or that relapses that are
almost systematically observed upon
HAART cessation could be prevented. If
an HSC-based reservoir is a functionally
relevant source of virus contributing to
this rebound, this is no surprise, as the
listed agentsmay have little effect on virus
residing in this other reservoir.
One prediction of Carter et al.’s data is
that HIV isolates reactivated by cytokine
treatment of HSCs purified from the
bone marrow of HIV-infected individuals
should exhibit an X4 or a dual X4/R5
tropism. A clinically essential corollary is
that only patients in whom the R5-to-X4172 Cell Host & Microbe 9, March 17, 2011 ªswitch has already taken place should
harbor HIV-infected HSC. Finally, in such
patients, if HAART was interrupted after
long aviremic periods, the rebounding
viruses should include X4-tropic strains.
These points warrant investigation.
Indeed, if they were verified, it would
imply that the establishment of a theoreti-
cally inexpugnable latent reservoir in mul-
tipotent HSCs occurs only relatively late in
the course of HIV infection. Accordingly, it
should be preventable by the early instau-
ration of HAART. This would add to the list
of arguments in favor of a therapeutic
attitude already advocated to minimize
the size of the global latent reservoir and
the amount of damage inflicted on the
immune system, particularly in the gut,
during the early times of infection
(Brenchley et al., 2006). Whether this
might open the door to HIV eradication
remains an open question.REFERENCES
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HIV-1 engages the cellular ESCRT-III/VPS4 membrane scission machinery for its escape from host cells.
Three papers now begin to demystify its mode of action by showing that HIV-1 requires only the transient
recruitment of a surprisingly small subset of ESCRT-III components, whose membrane abscission function
depends on VPS4 activity.TheESCRTpathway consists of a network
of protein complexes (ESCRT-0 to -III) and
of associated proteins such as VPS4 and
ALIX. ESCRT complexes are recruited
during diverse cellular processes ranging
from multivesicular body (MVB) biogen-
esis and cytokinesis to the budding of
some enveloped viruses, such as HIV-1
(Bieniasz, 2006; Hurley and Hanson,
2010; Peel et al., 2010; Saksena et al.,2007). All these processes ultimately
depend on the scission of membrane
necks with an unusual topology, which is
carried out by ESCRT-III (Hurley and
Hanson, 2010).
ESCRT-III assembles from monomeric
cytosolic subunits, producing mem-
brane-associated helical filaments. The
assembly of such filaments within bud
necks is thought to induce membraneconstriction, eventually leading to mem-
brane fission (Peel et al., 2010). Interest-
ingly, ESCRT-III subunits can assemble
into helical tubules with dome-like caps
(Lata et al., 2008), suggesting that
membrane scission could ultimately be
driven by ESCRT-III domes that narrow
bud necks from their cytosolic side until
spontaneous fission occurs (Peel et al.,
2010).
